| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |